Home
AXDX
AXDX News

Latest Accelerate Diagnostics Inc. (AXDX) News on December 19, 2024

Thomson Reuters StreetEvents

a month ago

Q3 2024 Accelerate Diagnostics Inc Earnings Call

GuruFocus.com

a month ago

Accelerate Diagnostics Inc (AXDX) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...

Accelerate Diagnostics (AXDX) Reports Q3 Loss, Lags Revenue Estimates

Zacks

a month ago

Accelerate Diagnostics (AXDX) Reports Q3 Loss, Lags Revenue Estimates

Associated Press Finance

a month ago

Accelerate Diagnostics: Q3 Earnings Snapshot

Accelerate Diagnostics Reports Third Quarter 2024 Financial Results

PR Newswire

a month ago

Accelerate Diagnostics Reports Third Quarter 2024 Financial Results

Accelerate Diagnostics Scheduled Call to Review 2024 Third Quarter Results

PR Newswire

2 months ago

Accelerate Diagnostics Scheduled Call to Review 2024 Third Quarter Results

GuruFocus.com

2 months ago

Accelerate Diagnostics Inc (AXDX) Q2 2024 Earnings Call Highlights: Strategic Advances Amid ...

Accelerate Diagnostics Stock Down Despite FDA Clearance for Arc System

Zacks

3 months ago

Accelerate Diagnostics Stock Down Despite FDA Clearance for Arc System

FDA approves Accelerate Arc system to identify microbial infections

Medical Device Network

3 months ago

FDA approves Accelerate Arc system to identify microbial infections

MT Newswires

3 months ago

Accelerate Diagnostics Says FDA Grants Clearance for Automated Blood Culture Platform

Accelerate Diagnostics Announces FDA Clearance of its Accelerate Arc™ System

PR Newswire

3 months ago

Accelerate Diagnostics Announces FDA Clearance of its Accelerate Arc™ System

Accelerate Diagnostics (AXDX) Completes WAVE Pre-Clinical Trial

Zacks

4 months ago

Accelerate Diagnostics (AXDX) Completes WAVE Pre-Clinical Trial

Accelerate Diagnostics (AXDX) Reports Q2 Loss, Misses Revenue Estimates

Zacks

4 months ago

Accelerate Diagnostics (AXDX) Reports Q2 Loss, Misses Revenue Estimates

Associated Press Finance

4 months ago

Accelerate Diagnostics: Q2 Earnings Snapshot

Accelerate Diagnostics Reports Second Quarter 2024 Financial Results

PR Newswire

4 months ago

Accelerate Diagnostics Reports Second Quarter 2024 Financial Results

Accelerate Diagnostics Announces a Successful Completion of its WAVE™ Pre-Clinical Trial

PR Newswire

4 months ago

Accelerate Diagnostics Announces a Successful Completion of its WAVE™ Pre-Clinical Trial

Accelerate Diagnostics Scheduled Call to Review 2024 Second Quarter Results

PR Newswire

4 months ago

Accelerate Diagnostics Scheduled Call to Review 2024 Second Quarter Results

Ekso Bionics (EKSO) Reports Q2 Loss, Lags Revenue Estimates

Zacks

5 months ago

Ekso Bionics (EKSO) Reports Q2 Loss, Lags Revenue Estimates

Italian energy company targets Britain for fleet of 20 mini-nukes

The Telegraph

6 months ago

Italian energy company targets Britain for fleet of 20 mini-nukes

It Might Not Be A Great Idea To Buy StepStone Group LP (NASDAQ:STEP) For Its Next Dividend

Simply Wall St.

6 months ago

It Might Not Be A Great Idea To Buy StepStone Group LP (NASDAQ:STEP) For Its Next Dividend

Is Now The Time To Put Planet Fitness (NYSE:PLNT) On Your Watchlist?

Simply Wall St.

6 months ago

Is Now The Time To Put Planet Fitness (NYSE:PLNT) On Your Watchlist?

Don't Buy Banc of California, Inc. (NYSE:BANC) For Its Next Dividend Without Doing These Checks

Simply Wall St.

6 months ago

Don't Buy Banc of California, Inc. (NYSE:BANC) For Its Next Dividend Without Doing These Checks

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Motley Fool

6 months ago

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Should You Be Adding Mueller Water Products (NYSE:MWA) To Your Watchlist Today?

Simply Wall St.

6 months ago

Should You Be Adding Mueller Water Products (NYSE:MWA) To Your Watchlist Today?

Graham Full Year 2024 Earnings: EPS: US$0.42 (vs US$0.035 in FY 2023)

Simply Wall St.

6 months ago

Graham Full Year 2024 Earnings: EPS: US$0.42 (vs US$0.035 in FY 2023)

Seoul resumes loudspeaker propaganda against North

AFP

6 months ago

Seoul resumes loudspeaker propaganda against North

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Q1 2024 Earnings Call Transcript

Insider Monkey

7 months ago

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Q1 2024 Earnings Call Transcript

Thomson Reuters StreetEvents

7 months ago

Q1 2024 Accelerate Diagnostics Inc Earnings Call

GuruFocus.com

7 months ago

Accelerate Diagnostics Inc (AXDX) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...

Accelerate Diagnostics (AXDX) Reports Q1 Loss, Misses Revenue Estimates

Zacks

7 months ago

Accelerate Diagnostics (AXDX) Reports Q1 Loss, Misses Revenue Estimates

Associated Press Finance

7 months ago

Accelerate Diagnostics: Q1 Earnings Snapshot

Accelerate Diagnostics Reports Preliminary First Quarter 2024 Financial Results

PR Newswire

7 months ago

Accelerate Diagnostics Reports Preliminary First Quarter 2024 Financial Results

Will Accelerate Diagnostics (AXDX) Report Negative Q1 Earnings? What You Should Know

Zacks

8 months ago

Will Accelerate Diagnostics (AXDX) Report Negative Q1 Earnings? What You Should Know

Accelerate Diagnostics Scheduled Call to Review 2024 First Quarter Results.

PR Newswire

8 months ago

Accelerate Diagnostics Scheduled Call to Review 2024 First Quarter Results.

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Q4 2023 Earnings Call Transcript

Insider Monkey

9 months ago

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Q4 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

9 months ago

Q4 2023 Accelerate Diagnostics Inc Earnings Call

Accelerate Diagnostics (AXDX) Reports Q4 Loss, Misses Revenue Estimates

Zacks

9 months ago

Accelerate Diagnostics (AXDX) Reports Q4 Loss, Misses Revenue Estimates

Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial Results

PR Newswire

9 months ago

Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial Results

Accelerate Diagnostics Scheduled Call to Review 2023 Fourth Quarter and Full Year Results.

PR Newswire

9 months ago

Accelerate Diagnostics Scheduled Call to Review 2023 Fourth Quarter and Full Year Results.

LeddarTech to Host Investor & Business Update Call on January 31, 2024

PR Newswire

a year ago

LeddarTech to Host Investor & Business Update Call on January 31, 2024

Incannex Commences Dosing in Phase 2 Clinical Trial Assessing IHL-675A in Patients with Rheumatoid Arthritis

GlobeNewswire

a year ago

Incannex Commences Dosing in Phase 2 Clinical Trial Assessing IHL-675A in Patients with Rheumatoid Arthritis

Theratechnologies Receives Complete Response Letter (CRL) from the FDA for the F8 Formulation of Tesamorelin sBLA

GlobeNewswire

a year ago

Theratechnologies Receives Complete Response Letter (CRL) from the FDA for the F8 Formulation of Tesamorelin sBLA

SurgePays Announces Closing of $15 Million Public Offering

GlobeNewswire

a year ago

SurgePays Announces Closing of $15 Million Public Offering

Accelerate Diagnostics Announces Pricing of Approximately $15 Million Public Offering and Private Placement

PR Newswire

a year ago

Accelerate Diagnostics Announces Pricing of Approximately $15 Million Public Offering and Private Placement

Lipocine and Verity Pharma Enter into License Agreement for TLANDO® Franchise in the U.S. and Canada

PR Newswire

a year ago

Lipocine and Verity Pharma Enter into License Agreement for TLANDO® Franchise in the U.S. and Canada

Safety Shot Responds to FSD Pharma’s 3rd unauthorized Tagging of its Stock and Making False Claims in an Effort to Harm the Company and its Shareholders

GlobeNewswire

a year ago

Safety Shot Responds to FSD Pharma’s 3rd unauthorized Tagging of its Stock and Making False Claims in an Effort to Harm the Company and its Shareholders

FingerMotion Reports Q3 2024 Financial Results

ACCESSWIRE

a year ago

FingerMotion Reports Q3 2024 Financial Results

Accelerate Diagnostics Announces Launch of Proposed Public Offering

PR Newswire

a year ago

Accelerate Diagnostics Announces Launch of Proposed Public Offering

Business Wire

a year ago

Xos and ElectraMeccanica Announce Proposed Combination to Accelerate Xos’ Leadership Position in Manufacturing Commercial Electric Vehicles for Major U.S. Fleet Customers

ZeroFox to Participate in 26th Annual Needham Growth Conference

GlobeNewswire

a year ago

ZeroFox to Participate in 26th Annual Needham Growth Conference

Spire Global to Launch the First Commercial Space Situational Awareness Satellite Constellation for NorthStar Earth & Space

Business Wire

a year ago

Spire Global to Launch the First Commercial Space Situational Awareness Satellite Constellation for NorthStar Earth & Space

Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2023 Results

PR Newswire

a year ago

Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2023 Results

Vincerx Pharma Announces Compelling Clinical Efficacy of Enitociclib in Combination with Venetoclax and Prednisone in Lymphoma

GlobeNewswire

a year ago

Vincerx Pharma Announces Compelling Clinical Efficacy of Enitociclib in Combination with Venetoclax and Prednisone in Lymphoma

Nutriband Signs Commercial Development and Clinical Supply Agreement With Kindeva Drug Delivery for Aversa(TM) Fentanyl, an Abuse Deterrent Fentanyl Patch

ACCESSWIRE

a year ago

Nutriband Signs Commercial Development and Clinical Supply Agreement With Kindeva Drug Delivery for Aversa(TM) Fentanyl, an Abuse Deterrent Fentanyl Patch

3 EV Stocks to Sell in January Before They Crash and Burn

InvestorPlace

a year ago

3 EV Stocks to Sell in January Before They Crash and Burn

Daré Bioscience’s DARE-LARC1 Platform Technology Achieves Proof-of-Concept Device that has Transformative Potential for Women’s Health as well as in Treating a Broad Range of Diseases

GlobeNewswire

a year ago

Daré Bioscience’s DARE-LARC1 Platform Technology Achieves Proof-of-Concept Device that has Transformative Potential for Women’s Health as well as in Treating a Broad Range of Diseases

Trevi Therapeutics Provides Business Updates

PR Newswire

a year ago

Trevi Therapeutics Provides Business Updates

GlobeNewswire

a year ago

Safety Shot to Garner Global Exposure with its Brand Activation Event at Coachella—One of the Top Music Festivals in the World

Village Farms International Announces Launch of Top-Selling Cannabis Brands in the UK

GlobeNewswire

a year ago

Village Farms International Announces Launch of Top-Selling Cannabis Brands in the UK

Electrovaya Announces Date for Q4 FY-2023 and FY-2023 Financial Results and Conference Call

ACCESSWIRE

a year ago

Electrovaya Announces Date for Q4 FY-2023 and FY-2023 Financial Results and Conference Call

11 Cheap Pot Stocks to Buy

Insider Monkey

a year ago

11 Cheap Pot Stocks to Buy

Christmas Moviegoers’ Gift to Theaters, Plus the Top Films of 2023

Barrons.com

a year ago

Christmas Moviegoers’ Gift to Theaters, Plus the Top Films of 2023

Swvl Reports First Half 2023 Financial Results

GlobeNewswire

a year ago

Swvl Reports First Half 2023 Financial Results

Perma-Fix Joint Venture Receives Formal Award of European Waste Treatment Contract Valued at up to EUR 50 Million

GlobeNewswire

a year ago

Perma-Fix Joint Venture Receives Formal Award of European Waste Treatment Contract Valued at up to EUR 50 Million

Palatin Completes Sale of Vyleesi® to Cosette Pharmaceuticals for up to $171 Million

PR Newswire

a year ago

Palatin Completes Sale of Vyleesi® to Cosette Pharmaceuticals for up to $171 Million

We Think VirnetX Holding (NYSE:VHC) Needs To Drive Business Growth Carefully

Simply Wall St.

a year ago

We Think VirnetX Holding (NYSE:VHC) Needs To Drive Business Growth Carefully

Movano Health Announces Blood Pressure Partnership Forum Following Significant Response to Groundbreaking Accuracy Achievement

PR Newswire

a year ago

Movano Health Announces Blood Pressure Partnership Forum Following Significant Response to Groundbreaking Accuracy Achievement

The Zacks Analyst Blog Highlights Biogen, Prothena, AC Immune's and Vaxxinity

Zacks

a year ago

The Zacks Analyst Blog Highlights Biogen, Prothena, AC Immune's and Vaxxinity

Nektar and Collaborators Present Preclinical Data on NKTR-255 Combined with Obinutuzumab in Poster Presentation at the 65th American Society of Hematology (ASH) Annual Meeting

PR Newswire

a year ago

Nektar and Collaborators Present Preclinical Data on NKTR-255 Combined with Obinutuzumab in Poster Presentation at the 65th American Society of Hematology (ASH) Annual Meeting

IZEA Reports Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)

GlobeNewswire

a year ago

IZEA Reports Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)

Accelerate Diagnostics (AXDX) Expands in In Vitro Diagnostics

Zacks

a year ago

Accelerate Diagnostics (AXDX) Expands in In Vitro Diagnostics

Bruker's (BRKR) New Collaboration to Use MALDI Biotyper System

Zacks

a year ago

Bruker's (BRKR) New Collaboration to Use MALDI Biotyper System

Accelerate Diagnostics Announces Collaboration for the Use of the Arc™ System in Combination With Bruker´s MALDI Biotyper®

PR Newswire

a year ago

Accelerate Diagnostics Announces Collaboration for the Use of the Arc™ System in Combination With Bruker´s MALDI Biotyper®

Accelerate Diagnostics (AXDX) Loses -25.65% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Zacks

a year ago

Accelerate Diagnostics (AXDX) Loses -25.65% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Cardiff Oncology to Present at the 35th Annual Piper Sandler Healthcare Conference

PR Newswire

a year ago

Cardiff Oncology to Present at the 35th Annual Piper Sandler Healthcare Conference

Vicarious Surgical to Present at the Piper Sandler 35th Annual Healthcare Conference

Business Wire

a year ago

Vicarious Surgical to Present at the Piper Sandler 35th Annual Healthcare Conference

Precision Optics Reports First Quarter Fiscal Year 2024 Financial Results

PR Newswire

a year ago

Precision Optics Reports First Quarter Fiscal Year 2024 Financial Results

Calidi Biotherapeutics Reports Third Quarter 2023 Operating and Financial Results

Business Wire

a year ago

Calidi Biotherapeutics Reports Third Quarter 2023 Operating and Financial Results

PDS Biotechnology Corp (PDSB) Reports Increased Net Loss in Q3 2023 Amid Advancements in ...

GuruFocus.com

a year ago

PDS Biotechnology Corp (PDSB) Reports Increased Net Loss in Q3 2023 Amid Advancements in ...

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Q3 2023 Earnings Call Transcript

Income Opportunity Realty Investors, Inc. reports Earnings for Quarter Ended September 30, 2023

Business Wire

a year ago

Income Opportunity Realty Investors, Inc. reports Earnings for Quarter Ended September 30, 2023

Barinthus Bio Presents Interim Data from Phase 2b HBV003 Trial and Phase 2a AB-729-202 Trial in Collaboration with Arbutus Biopharma in Chronic HBV Patients at AASLD

GlobeNewswire

a year ago

Barinthus Bio Presents Interim Data from Phase 2b HBV003 Trial and Phase 2a AB-729-202 Trial in Collaboration with Arbutus Biopharma in Chronic HBV Patients at AASLD

Aqua Metals, Inc. (NASDAQ:AQMS) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

Aqua Metals, Inc. (NASDAQ:AQMS) Q3 2023 Earnings Call Transcript

a.k.a. Brands Holding Corp. Reports Third Quarter 2023 Financial Results

Business Wire

a year ago

a.k.a. Brands Holding Corp. Reports Third Quarter 2023 Financial Results

Spruce Biosciences to Participate in the Jefferies London Healthcare Conference

Business Wire

a year ago

Spruce Biosciences to Participate in the Jefferies London Healthcare Conference

Beasley Broadcast Group, Inc. (NASDAQ:BBGI) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

Beasley Broadcast Group, Inc. (NASDAQ:BBGI) Q3 2023 Earnings Call Transcript

ATI PHYSICAL THERAPY OPENS A NEW LOCATION IN MARYLAND

PR Newswire

a year ago

ATI PHYSICAL THERAPY OPENS A NEW LOCATION IN MARYLAND

Share on Social Networks: